# Semtech Corp: financial statements, quarterly

SMTC · Nasdaq · CIK 88941 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/smtc.md) · [Financials](/companies/smtc/financials.md) · [Filings](/companies/smtc/filings.md) · [Insiders](/companies/smtc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/smtc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-07-30) | Q3 FY2023 (2023-10-29) | Q4 FY2023 (2024-01-28) | Q1 FY2024 (2024-04-28) | Q2 FY2024 (2024-07-28) | Q3 FY2024 (2024-10-27) | Q4 FY2024 (2025-01-26) | Q1 FY2025 (2025-04-27) | Q2 FY2025 (2025-07-27) | Q3 FY2025 (2025-10-26) | Q4 FY2025 (2026-01-25) | Q1 FY2026 (2026-04-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [238](/filings/0000088941-24-000118.md) | [201](/filings/0000088941-24-000131.md) | [193 d](/filings/0000088941-26-000005.md) | [206](/filings/0000088941-25-000101.md) | [215](/filings/0000088941-25-000160.md) | [237](/filings/0000088941-25-000166.md) | [251 d](/filings/0000088941-26-000005.md) | [251](/filings/0000088941-26-000013.md) | [258](/filings/0000088941-25-000160.md) | [267](/filings/0000088941-25-000166.md) | [274 d](/filings/0000088941-26-000005.md) | [291](/filings/0000088941-26-000013.md) |
| Cost of revenue | $m | [138](/filings/0000088941-24-000118.md) | [108](/filings/0000088941-24-000131.md) | [193 d](/filings/0000088941-26-000005.md) | [107](/filings/0000088941-25-000101.md) | [110](/filings/0000088941-25-000160.md) | [116](/filings/0000088941-25-000166.md) | [120 d](/filings/0000088941-26-000005.md) | [120](/filings/0000088941-26-000013.md) | [123](/filings/0000088941-25-000160.md) | [128](/filings/0000088941-25-000166.md) | [136 d](/filings/0000088941-26-000005.md) | [140](/filings/0000088941-26-000013.md) |
| Gross profit | $m | [101](/filings/0000088941-24-000118.md) | [93.0](/filings/0000088941-24-000131.md) | [(0.4) d](/filings/0000088941-26-000005.md) | [99.6](/filings/0000088941-25-000101.md) | [105](/filings/0000088941-25-000160.md) | [121](/filings/0000088941-25-000166.md) | [131 d](/filings/0000088941-26-000005.md) | [131](/filings/0000088941-26-000013.md) | [134](/filings/0000088941-25-000160.md) | [138](/filings/0000088941-25-000166.md) | [138 d](/filings/0000088941-26-000005.md) | [151](/filings/0000088941-26-000013.md) |
| Research and development | $m | [47.4](/filings/0000088941-24-000118.md) | [46.9](/filings/0000088941-24-000131.md) | [41.5 d](/filings/0000088941-26-000005.md) | [41.6](/filings/0000088941-25-000101.md) | [40.1](/filings/0000088941-25-000160.md) | [42.6](/filings/0000088941-25-000166.md) | [46.7 d](/filings/0000088941-26-000005.md) | [47.5](/filings/0000088941-26-000013.md) | [48.2](/filings/0000088941-25-000160.md) | [49.4](/filings/0000088941-25-000166.md) | [51.2 d](/filings/0000088941-26-000005.md) | [57.6](/filings/0000088941-26-000013.md) |
| Selling, general and administrative | $m | [59.6](/filings/0000088941-24-000118.md) | [47.7](/filings/0000088941-24-000131.md) | [55.2 d](/filings/0000088941-26-000005.md) | [52.3](/filings/0000088941-25-000101.md) | [55.8](/filings/0000088941-25-000160.md) | [59.8](/filings/0000088941-25-000166.md) | [54.5 d](/filings/0000088941-26-000005.md) | [46.4](/filings/0000088941-26-000013.md) | [58.5](/filings/0000088941-25-000160.md) | [57.1](/filings/0000088941-25-000166.md) | [59.8 d](/filings/0000088941-26-000005.md) | [66.6](/filings/0000088941-26-000013.md) |
| Operating income | $m | [(300)](/filings/0000088941-24-000118.md) | [(12.4)](/filings/0000088941-24-000131.md) | [(620) d](/filings/0000088941-26-000005.md) | [3.1](/filings/0000088941-25-000101.md) | [7.8](/filings/0000088941-25-000160.md) | [17.8](/filings/0000088941-25-000166.md) | [21.2 d](/filings/0000088941-26-000005.md) | [36.0](/filings/0000088941-26-000013.md) | [(16.2)](/filings/0000088941-25-000160.md) | [31.1](/filings/0000088941-25-000166.md) | [(18.3) d](/filings/0000088941-26-000005.md) | [25.8](/filings/0000088941-26-000013.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [56.6](/filings/0000088941-24-000118.md) | [(0.3)](/filings/0000088941-24-000131.md) | [(3.3) d](/filings/0000088941-26-000005.md) | [3.0](/filings/0000088941-25-000101.md) | [4.2](/filings/0000088941-25-000160.md) | [4.0](/filings/0000088941-25-000166.md) | [(33.2) d](/filings/0000088941-26-000005.md) | [8.7](/filings/0000088941-26-000013.md) | [4.8](/filings/0000088941-25-000160.md) | [7.3](/filings/0000088941-25-000166.md) | [(0.9) d](/filings/0000088941-26-000005.md) | [0.1](/filings/0000088941-26-000013.md) |
| Net income | $m | [(382)](/filings/0000088941-24-000118.md) | [(38.3)](/filings/0000088941-24-000131.md) | [(642) d](/filings/0000088941-26-000005.md) | [(23.2)](/filings/0000088941-25-000101.md) | [(170)](/filings/0000088941-25-000160.md) | [(7.6)](/filings/0000088941-25-000166.md) | [39.1 d](/filings/0000088941-26-000005.md) | [19.3](/filings/0000088941-26-000013.md) | [(27.1)](/filings/0000088941-25-000160.md) | [(2.9)](/filings/0000088941-25-000166.md) | [(29.8) d](/filings/0000088941-26-000005.md) | [26.6](/filings/0000088941-26-000013.md) |
| Diluted EPS | $ per share | [(5.97)](/filings/0000088941-24-000118.md) | [(0.60)](/filings/0000088941-24-000131.md) | not reported | [(0.36)](/filings/0000088941-25-000101.md) | [(2.61)](/filings/0000088941-25-000160.md) | [(0.10)](/filings/0000088941-25-000166.md) | not reported | [0.22](/filings/0000088941-26-000013.md) | [(0.31)](/filings/0000088941-25-000160.md) | [(0.03)](/filings/0000088941-25-000166.md) | not reported | [0.27](/filings/0000088941-26-000013.md) |
| Basic EPS | $ per share | [(5.97)](/filings/0000088941-24-000118.md) | [(0.60)](/filings/0000088941-24-000131.md) | not reported | [(0.36)](/filings/0000088941-25-000101.md) | [(2.61)](/filings/0000088941-25-000160.md) | [(0.10)](/filings/0000088941-25-000166.md) | not reported | [0.22](/filings/0000088941-26-000013.md) | [(0.31)](/filings/0000088941-25-000160.md) | [(0.03)](/filings/0000088941-25-000166.md) | not reported | [0.29](/filings/0000088941-26-000013.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-07-30) | Q3 FY2023 (2023-10-29) | FY2023 (2024-01-28) | Q1 FY2024 (2024-04-28) | Q2 FY2024 (2024-07-28) | Q3 FY2024 (2024-10-27) | FY2024 (2025-01-26) | Q1 FY2025 (2025-04-27) | Q2 FY2025 (2025-07-27) | Q3 FY2025 (2025-10-26) | FY2025 (2026-01-25) | Q1 FY2026 (2026-04-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [148](/filings/0000088941-23-000022.md) | [124](/filings/0000088941-23-000029.md) | [129](/filings/0000088941-25-000068.md) | [127](/filings/0000088941-24-000065.md) | [116](/filings/0000088941-24-000118.md) | [137](/filings/0000088941-24-000131.md) | [152](/filings/0000088941-26-000005.md) | [156](/filings/0000088941-25-000101.md) | [169](/filings/0000088941-25-000160.md) | [165](/filings/0000088941-25-000166.md) | [195](/filings/0000088941-26-000013.md) | [163](/filings/0000088941-26-000013.md) |
| Current assets | $m | [630](/filings/0000088941-23-000022.md) | [572](/filings/0000088941-23-000029.md) | [534](/filings/0000088941-25-000068.md) | [539](/filings/0000088941-24-000065.md) | [542](/filings/0000088941-24-000118.md) | [558](/filings/0000088941-24-000131.md) | [585](/filings/0000088941-26-000005.md) | [598](/filings/0000088941-25-000101.md) | [615](/filings/0000088941-25-000160.md) | [621](/filings/0000088941-25-000166.md) | [655](/filings/0000088941-26-000013.md) | [649](/filings/0000088941-26-000013.md) |
| Total assets | $m | [2,119](/filings/0000088941-23-000022.md) | [2,038](/filings/0000088941-23-000029.md) | [1,374](/filings/0000088941-25-000068.md) | [1,377](/filings/0000088941-24-000065.md) | [1,368](/filings/0000088941-24-000118.md) | [1,379](/filings/0000088941-24-000131.md) | [1,419](/filings/0000088941-26-000005.md) | [1,432](/filings/0000088941-25-000101.md) | [1,406](/filings/0000088941-25-000160.md) | [1,406](/filings/0000088941-25-000166.md) | [1,410](/filings/0000088941-26-000013.md) | [1,439](/filings/0000088941-26-000013.md) |
| Current liabilities | $m | [321](/filings/0000088941-23-000022.md) | [239](/filings/0000088941-23-000029.md) | [217](/filings/0000088941-25-000068.md) | [225](/filings/0000088941-24-000065.md) | [225](/filings/0000088941-24-000118.md) | [235](/filings/0000088941-24-000131.md) | [283](/filings/0000088941-26-000005.md) | [236](/filings/0000088941-25-000101.md) | [243](/filings/0000088941-25-000160.md) | [255](/filings/0000088941-25-000166.md) | [276](/filings/0000088941-26-000013.md) | [274](/filings/0000088941-26-000013.md) |
| Long-term debt | $m | [1,331](/filings/0000088941-23-000022.md) | [1,374](/filings/0000088941-23-000029.md) | [1,371](/filings/0000088941-25-000068.md) | [1,373](/filings/0000088941-24-000065.md) | [1,193](/filings/0000088941-24-000118.md) | [1,190](/filings/0000088941-24-000131.md) | [506](/filings/0000088941-26-000005.md) | [543](/filings/0000088941-25-000101.md) | [519](/filings/0000088941-25-000160.md) | [490](/filings/0000088941-25-000166.md) | [491](/filings/0000088941-26-000013.md) | [492](/filings/0000088941-26-000013.md) |
| Current portion of debt | $m | [52.9](/filings/0000088941-23-000022.md) | [0.0](/filings/0000088941-23-000029.md) | [0.0](/filings/0000088941-25-000068.md) | not reported | not reported | not reported | [45.6](/filings/0000088941-26-000005.md) | [0.0](/filings/0000088941-25-000101.md) | [0.0](/filings/0000088941-25-000160.md) | [0.0](/filings/0000088941-25-000166.md) | [0.0](/filings/0000088941-26-000005.md) | not reported |
| Shareholders' equity | $m | [367](/filings/0000088941-23-000022.md) | [334](/filings/0000088941-23-000029.md) | [(307)](/filings/0000088941-25-000068.md) | [(313)](/filings/0000088941-24-000065.md) | [(141)](/filings/0000088941-24-000118.md) | [(140)](/filings/0000088941-24-000131.md) | [542](/filings/0000088941-26-000005.md) | [569](/filings/0000088941-25-000101.md) | [553](/filings/0000088941-25-000166.md) | [566](/filings/0000088941-25-000166.md) | [550](/filings/0000088941-26-000005.md) | [573](/filings/0000088941-26-000013.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-07-30) | Q3 FY2023 (2023-10-29) | Q4 FY2023 (2024-01-28) | Q1 FY2024 (2024-04-28) | Q2 FY2024 (2024-07-28) | Q3 FY2024 (2024-10-27) | Q4 FY2024 (2025-01-26) | Q1 FY2025 (2025-04-27) | Q2 FY2025 (2025-07-27) | Q3 FY2025 (2025-10-26) | Q4 FY2025 (2026-01-25) | Q1 FY2026 (2026-04-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(12.0) d](/filings/0000088941-24-000118.md) | [(5.8) d](/filings/0000088941-24-000131.md) | [13.9 d](/filings/0000088941-26-000005.md) | [(0.1)](/filings/0000088941-25-000101.md) | [(5.0) d](/filings/0000088941-25-000160.md) | [29.6 d](/filings/0000088941-25-000166.md) | [33.5 d](/filings/0000088941-26-000005.md) | [27.8](/filings/0000088941-26-000013.md) | [44.4 d](/filings/0000088941-25-000160.md) | [47.5 d](/filings/0000088941-25-000166.md) | [61.5 d](/filings/0000088941-26-000005.md) | [36.2](/filings/0000088941-26-000013.md) |
| Capital expenditure | $m | [6.9 d](/filings/0000088941-24-000118.md) | [6.6 d](/filings/0000088941-24-000131.md) | [1.7 d](/filings/0000088941-26-000005.md) | [1.3](/filings/0000088941-25-000101.md) | [3.4 d](/filings/0000088941-25-000160.md) | [0.5 d](/filings/0000088941-25-000166.md) | [2.6 d](/filings/0000088941-26-000005.md) | [1.7](/filings/0000088941-26-000013.md) | [2.9 d](/filings/0000088941-25-000160.md) | [2.8 d](/filings/0000088941-25-000166.md) | [2.4 d](/filings/0000088941-26-000005.md) | [8.2](/filings/0000088941-26-000013.md) |
| Share repurchases | $m | [0.0 d](/filings/0000088941-23-000022.md) | [0.0 d](/filings/0000088941-23-000029.md) | [0.0 d](/filings/0000088941-25-000068.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-07-31) | Q3 FY2022 (2022-10-30) | Q1 FY2023 (2023-04-30) | Q2 FY2023 (2023-07-30) | Q3 FY2023 (2023-10-29) | Q1 FY2024 (2024-04-28) | Q2 FY2024 (2024-07-28) | Q3 FY2024 (2024-10-27) | Q1 FY2025 (2025-04-27) | Q2 FY2025 (2025-07-27) | Q3 FY2025 (2025-10-26) | Q1 FY2026 (2026-04-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [64.0](/filings/0000088941-23-000022.md) | [63.9](/filings/0000088941-23-000029.md) | [63.9](/filings/0000088941-24-000065.md) | [64.0](/filings/0000088941-24-000118.md) | [64.2](/filings/0000088941-24-000131.md) | [64.5](/filings/0000088941-25-000101.md) | [65.3](/filings/0000088941-25-000160.md) | [75.3](/filings/0000088941-25-000166.md) | [89.6](/filings/0000088941-26-000013.md) | [86.7](/filings/0000088941-25-000160.md) | [87.7](/filings/0000088941-25-000166.md) | [98.0](/filings/0000088941-26-000013.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 93,151,168 at 2026-05-22, from the cover of the [10-Q filed 2026-05-27](/filings/0000088941-26-000013.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.